Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance

Chemical Science
Mun Juinn ChowChristian Gaiddon

Abstract

Multidrug resistance (MDR) is a major impediment to the success of chemotherapy in many cancer types. One particular MDR mechanism is the inherent or acquired adaptation of the cellular survival pathways that render malignant cells resistant to apoptotic cell death. Since most drugs act through apoptosis, compounds capable of inducing alternative forms of programmed cell death (PCD) can potentially be harnessed to bypass MDR. We investigated two organoruthenium complexes, RAS-1H and RAS-1T, and demonstrated that although they both induced non-apoptotic PCD through ER stress pathways, their modes-of-action were drastically different despite modest structural variations. RAS-1T acted through ROS-mediated ER stress while RAS-1H was ROS-independent. We further showed that they were more efficacious against apoptosis-resistant cells compared to clinical drugs including oxaliplatin. This work provides the basis for underpinning ER stress modulation using metal complexes to bypass apoptosis resistance.

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·M J SmythR W Johnstone
Mar 23, 2000·Cardiovascular Research·A Saraste, K Pulkki
Mar 13, 2001·Leukemia·D M O'Gorman, T G Cotter
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Sabine VioletteThécla Lesuffleur
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Dec 20, 2003·Cell Death and Differentiation·S Oyadomari, M Mori
Jan 6, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·Graeme MorganMichael Barton
Jan 25, 2005·Cell Death and Differentiation·U Fischer, K Schulze-Osthoff
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Dec 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fuyi WangPeter J Sadler
Jan 24, 2006·The Biochemical Journal·Valeska VollrathJose Chianale
Jun 15, 2007·Nature Reviews. Molecular Cell Biology·David Ron, Peter Walter
Oct 20, 2007·Expert Review of Anticancer Therapy·Dexin Zhang, Daiming Fan
Nov 6, 2007·Antioxidants & Redox Signaling·Jyoti D Malhotra, Randal J Kaufman
Jul 8, 2008·Molecular Aspects of Medicine·Shelly C Lu
Jul 12, 2008·Molecular Carcinogenesis·Wenge Li, Ah-Ng Kong
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Simone Fulda
Apr 2, 2011·Journal of the American Chemical Society·Saverio TarditoLuciano Marchiò
May 18, 2011·Chemical Communications : Chem Comm·Songhai TianChi-Ming Che
Oct 18, 2011·Chemical Communications : Chem Comm·Muhammad HanifChristian G Hartinger
Oct 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Harald EhrhardtIrmela Jeremias
Jan 19, 2012·Nature Reviews. Molecular Cell Biology·Claudio Hetz
Dec 25, 2012·International Journal of Molecular Sciences·Bidur BhandaryHan-Jung Chae
Sep 18, 2013·Journal of the American Chemical Society·Kogularamanan SuntharalingamStephen J Lippard
Jan 25, 2014·Chemical Reviews·Katja Dralle Mjos, Chris Orvig
Jan 1, 2013·Cells·Eric HervouetPierre-François Cartron
May 16, 2014·Metallomics : Integrated Biometal Science·Zuandi LuoTianfeng Chen
Aug 22, 2014·Molecular Cancer Research : MCR·Haraldur H SigurðssonStine F Pedersen
Aug 27, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yaqiong ZuJun Ma
Feb 24, 2015·Journal of the American Chemical Society·Kogularamanan SuntharalingamStephen J Lippard

❮ Previous
Next ❯

Citations

Mar 15, 2019·Chemical Communications : Chem Comm·Leli ZengHui Chao
May 16, 2019·Chemistry : a European Journal·A Paden KingJustin J Wilson
Sep 17, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Priyaranjan KumarAshis K Patra
Jul 13, 2018·Chemical Science·Ruilin GuanHui Chao
Jul 1, 2020·Chemical Society Reviews·A Paden King, Justin J Wilson
Jan 11, 2017·Chemistry : a European Journal·Dominique KreutzChristopher Gerner
Jun 29, 2017·Chemistry : a European Journal·Chunxin LuKogularamanan Suntharalingam
Sep 22, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·C LuK Suntharalingam
May 31, 2017·Chemistry : a European Journal·Marie FlammeKogularamanan Suntharalingam
Aug 11, 2020·Chembiochem : a European Journal of Chemical Biology·Pooja KaurKogularamanan Suntharalingam
May 26, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Priyaranjan KumarAshis K Patra
Jun 12, 2018·Inorganic Chemistry·Mohammad Mehdi HaghdoostAnnie Castonguay
May 14, 2016·Molecular Pharmaceutics·Mun Juinn ChowWee Han Ang
Aug 18, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Andreia ValentePetra Heffeter
Jul 8, 2020·Inorganic Chemistry·Sierra C MarkerJustin J Wilson
Jan 12, 2022·Chembiochem : a European Journal of Chemical Biology·Maria Azmanova, Anaïs Pitto-Barry

❮ Previous
Next ❯

Methods Mentioned

BETA
column chromatography
fluorescence microscopy

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.